The video follows three men, diagnosed with localised prostate cancer in their late forties and their early 50s, who have had to face life-changing decisions. All three men opted for prostate brachytherapy, a minimally invasive procedure which has the same high cure rate as surgery, but less risk of impotence and incontinence. (1)
The video highlights the importance of access to reliable information on treatment options and their side effects, and the impact that treatment choice may have on relationships, in particular, sexual function.
As Graham Robson, one of the men featured in the film, explains. “I was separated when I was diagnosed with prostate cancer, but I was hoping to be in a relationship again soon. My doctor advised me to have surgery and warned me that I may be left impotent and incontinent. At the time, I was just focused on staying alive and, if that meant that I would not be able to have sex again, then that was the price to pay.
A groundbreaking new clinical trial—the LDR BURST Study—is set to begin recruitment. Led by Dr Carla Perna and Dr William Hayhurst, the trial will compare two advanced radiotherapy techniques: Low Dose Rate (LDR) Brachytherapy and Stereotactic Body Radiotherapy (SBRT).
Professor Stephen Langley of Royal Surrey Cancer Centre, alongside Professor Frank Chinegwundoh of St George’s University of London, have written a letter to the editor of The Times in response to the article “Screening every man for prostate cancer isn’t as helpful as it sounds.”
On 26 March 2025, Professor Langley and colleagues led a landmark initiative by bringing the Man Van to the House of Commons, offering on-site prostate cancer testing to Members of Parliament and parliamentary staff.
The University of Surrey has conferred an Honorary Doctorate upon Professor Langley, in recognition of his pioneering contributions to prostate cancer detection and treatment, and his leadership in advancing research and care across Surrey and beyond.
Professor Langley was honoured to speak at the All-Party Parliamentary Group (APPG) on Prostate Cancer at the House of Commons this week, joining fellow clinicians, researchers, and policymakers to discuss the future of prostate cancer diagnostics and care across the UK.
The treatment selector table will help you to discuss with your partner and your healthcare team if you are suitable for prostate brachytherapy.
Prostate brachytherapy is the only minimally invasive surgical treatment option recommended by NICE
Latest data from The Prostate Brachytherapy Centre shows
The Prostate Cancer Charity is aiming to put prostate cancer on the top of everyone’s agenda to show it really does matter.